Nuvectis Pharma, Inc.
corporate_fare Company Profile
Nuvectis Pharma, Inc. (NASDAQ:NVCT) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 26 items for NVCT at importance 7 or higher on its 1–10 market-impact scale.
Recent high-impact activity:
- Nuvectis Licenses Two Clinical-Stage Compounds, NXP100 Shows Superiority to Soliris in Phase 3 PNH Trial
- Nuvectis Pharma Reports Widened Q1 Loss and Increased Cash Burn, Confirms 12-Month Runway
- Nuvectis Pharma Reports Widened Q1 Net Loss and Significant Cash Burn, Advances NXP900 Clinical Program
- Nuvectis Pharma Discloses Over $3.2M in Unpaid Executive Compensation Amidst Annual Meeting Preparations
- Nuvectis Pharma Files $150M Universal Shelf Registration, Including $60M At-The-Market Offering
Financial Snapshot
Fiscal year ended December 31, 2025
Net Income
-$26.44M
Diluted EPS
-$1.32
Op. Cash Flow
-$16.01M
Operating Income
-$27.57M
Cash & Equivalents
$31.63M
Debt / Equity
0.00×
Shares Outstanding
25.68M sh
Source: 10-K · filed 2026-02-11 · accession 0001104659-26-013044
show_chartPrice Chart
Loading chart...
feed NVCT - Filings & News (Page 2)
NVCT
Jun 22, 2026, 7:30 AM EDT
Price at Filing:
$14.20
Real-time Price:
$20.40
Change:
+$6.20 (+44%)
Market Cap:
$666.801M
NVCT
May 05, 2026, 9:03 AM EDT
Price at Filing:
$8.89
Real-time Price:
$20.40
Change:
+$11.51 (+129%)
Market Cap:
$666.801M
NVCT
May 05, 2026, 7:36 AM EDT
Price at Filing:
$8.89
Real-time Price:
$20.40
Change:
+$11.51 (+129%)
Market Cap:
$666.801M
NVCT
Apr 27, 2026, 4:37 PM EDT
Price at Filing:
$8.72
Real-time Price:
$20.40
Change:
+$11.68 (+134%)
Market Cap:
$666.801M
NVCT
Feb 13, 2026, 4:00 PM EST
Price at Filing:
$8.76
Real-time Price:
$20.40
Change:
+$11.64 (+133%)
Market Cap:
$666.801M
NVCT
Feb 11, 2026, 8:02 AM EST
Price at Filing:
$8.74
Real-time Price:
$20.40
Change:
+$11.66 (+133%)
Market Cap:
$666.801M